Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Transfection Reagents And Equipment Market Growth From $1.93 Billion In 2026 To $2.97 Billion By 2030 At A CAGR Of 11.3%
The transfection reagents and equipment market size has observed rapid expansion in recent years. It is projected to increase from $1.74 billion in 2025 to $1.93 billion in 2026, at a compound annual growth rate (CAGR) of 11.2%. The historical growth of this market can be ascribed to several factors, including the escalation of molecular biology research activities, the increased utilization of cell-based assays, the growth in recombinant protein production, the rising trend in academic and industrial genomics research, and the availability of advanced transfection chemistries.
The transfection reagents and equipment market size is projected to experience rapid expansion over the next few years. This market is anticipated to reach a value of $2.97 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.3%. The growth observed during the forecast period can be primarily attributed to the increasing integration of CRISPR and gene therapy research, a rising demand for scalable transfection platforms, the ongoing development and expansion of biopharmaceutical pipelines, augmented investment in precision medicine, and increased automation within life science laboratories. Prominent trends throughout the forecast period include a greater uptake of high-efficiency transfection reagents, a growing requirement for gene editing-compatible delivery systems, an increasing reliance on non-viral transfection methods, the proliferation of automated transfection instruments, and a heightened emphasis on cell-type specific transfection solutions.
Get A Free Sample Report With In-Depth Market Insights:
Transfection Reagents And Equipment Market Growth Backed By Core Demand Fundamentals
The increasing number of cancer patients globally is anticipated to propel the expansion of the transfection reagents and equipment market. Cancer is defined as a group of diseases characterized by cells that grow abnormally and without control. Transfection reagents are frequently utilized in cancer research to introduce foreign genetic material, such as plasmid DNA or RNA molecules, enabling researchers to investigate various aspects of cancer biology, including gene expression studies, gene silencing, drug screening, and target validation. For instance, in July 2024, projections released by Cancer Research UK, a UK-based cancer charity, indicated that cancer incidence rates in the United Kingdom are expected to rise for the majority of types between 2023-2025 and 2038-2040. These increases range from less than 1% for breast cancer to 50% for eye cancer, while a smaller number of cancers are predicted to decline, with reductions spanning from 2% for lung cancer to 27% for mesothelioma. Consequently, the rising worldwide count of cancer patients is a significant driver for the growth of the transfection reagents and equipment market.
Transfection Reagents And Equipment Market Segment Performance And Emerging Opportunities
The transfection reagents and equipment market covered in this report is segmented –
1) By Product: Instruments, Reagent And Kits
2) By Types Of Molecule: Plasmid DNA, DNA Oligonucleotides, Small Interfering RNA (SiRNA), Proteins, Ribonucleoprotein Complexes (RNPs), Other Molecules
3) By End User: Biopharma, Contract Research Organizations (CROs), Academia
Subsegments:
1) By Instruments: Electroporation Systems, Microinjection Systems, Particle Bombardment Systems
2) By Reagent And Kits: Lipid-Based Transfection Reagents, Polymer-Based Transfection Reagents, Protein-Based Transfection Reagents, Nucleic Acid Delivery Kits
Transfection Reagents And Equipment Market Growth Trends Reshaping The Competitive Landscape
Leading companies operating in the transfection reagents and equipment market are concentrating on developing innovative advancements, such as GMP-grade AAV transfection reagents, to improve viral vector production efficiency and support large-scale gene therapy manufacturing. A GMP-grade AAV transfection reagent is a regulatory-compliant chemical formulation designed to enable high-efficiency genetic material delivery into suspension cell cultures for the scalable production of recombinant adeno-associated virus vectors. For instance, in July 2025, Yeasen Biotechnology, a China-based biotechnology manufacturer, received U.S. Food and Drug Administration Drug Master File acceptance for its UltraAAV PEI Transfection Reagent—GMP grade. This reagent demonstrates substantially higher viral titers and significantly improved full capsid ratios across multiple adeno-associated virus serotypes, offering superior performance relative to standard formulations. It further enhances manufacturing efficiency by achieving comparable vector yields with reduced reagent usage while adhering to stringent regulatory and quality requirements suitable for clinical and commercial gene therapy production.
Transfection Reagents And Equipment Market Leading Players And Competitive Positioning
Major companies operating in the transfection reagents and equipment market are Thermo Fisher Scientific Inc., Promega Corporation, Qiagen N.V., Bio-Rad Laboratories Inc., MaxCyte Inc., Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, OriGene Technologies Inc., Altogen Biosystems, Applied Biological Materials Inc., Bex Co. Ltd., Takara Bio Inc., Polyplus-transfection SA, Sigma-Aldrich Corporation, Transfection Technologies Inc., Viromer, ABM Inc., chemicell GmbH, Genlantis, Biontech Laboratories GmbH, Jena Bioscience GmbH, PromoCell GmbH, PerkinElmer Inc., Sartorius AG, Hoffmann-La Roche Ltd., Bio-Techne Corporation, Biotium Inc., Cell Applications Inc.
View The Full Transfection Reagents And Equipment Market Report:
Transfection Reagents And Equipment Market Regional Distribution: Which Areas Power Market Growth?
North America was the largest region in the transfection reagents and equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection reagents and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model








